Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan: A Prospective Single Center, Open Label, Pilot Study

NCT01051960 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01051960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01051960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan: A Prospective Single Center, Open Label, Pilot Study
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
January 31, 2011
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, shortness of breath, systemic sclerosis